• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LRRK2 抑制散发性和家族性帕金森病中的蛋白质合成。

Protein synthesis is suppressed in sporadic and familial Parkinson's disease by LRRK2.

机构信息

Turku Bioscience, University of Turku and Åbo Akademi University, Turku, Finland.

Department of Immunotechnology, Lund University, Lund, Sweden.

出版信息

FASEB J. 2020 Nov;34(11):14217-14233. doi: 10.1096/fj.202001046R. Epub 2020 Sep 14.

DOI:10.1096/fj.202001046R
PMID:32926469
Abstract

Gain of function LRRK2-G2019S is the most frequent mutation found in familial and sporadic Parkinson's disease. It is expected therefore that understanding the cellular function of LRRK2 will provide insight on the pathological mechanism not only of inherited Parkinson's, but also of sporadic Parkinson's, the more common form. Here, we show that constitutive LRRK2 activity controls nascent protein synthesis in rodent neurons. Specifically, pharmacological inhibition of LRRK2, Lrrk2 knockdown or Lrrk2 knockout, all lead to increased translation. In the rotenone model for sporadic Parkinson's, LRRK2 activity increases, dopaminergic neuron translation decreases, and the neurites atrophy. All are prevented by LRRK2 inhibitors. Moreover, in striatum and substantia nigra of rotenone treated rats, phosphorylation changes are observed on eIF2α-S52(↑), eIF2s2-S2(↓), and eEF2-T57(↑) in directions that signify protein synthesis arrest. Significantly, translation is reduced by 40% in fibroblasts from Parkinson's patients (G2019S and sporadic cases alike) and this is reversed upon LRRK2 inhibitor treatment. In cells from multiple system atrophy patients, translation is unchanged suggesting that repression of translation is specific to Parkinson's disease. These findings indicate that repression of translation is a proximal function of LRRK2 in Parkinson's pathology.

摘要

LRRK2-G2019S 的功能获得性突变是家族性和散发性帕金森病中最常见的突变。因此,预计了解 LRRK2 的细胞功能不仅将为遗传性帕金森病的病理机制提供深入了解,也将为更为常见的散发性帕金森病提供深入了解。在这里,我们表明组成性 LRRK2 活性控制着啮齿动物神经元中新生蛋白的合成。具体而言,LRRK2 的药理学抑制、Lrrk2 敲低或 Lrrk2 敲除,都会导致翻译增加。在散发性帕金森病的鱼藤酮模型中,LRRK2 活性增加,多巴胺能神经元翻译减少,神经突萎缩。所有这些都可以被 LRRK2 抑制剂预防。此外,在鱼藤酮处理的大鼠纹状体和黑质中,观察到 eIF2α-S52(↑)、eIF2s2-S2(↓)和 eEF2-T57(↑)上的磷酸化变化,这些变化表明蛋白质合成被阻断。重要的是,帕金森病患者(G2019S 和散发性病例)的成纤维细胞中的翻译减少了 40%,而 LRRK2 抑制剂治疗后则逆转了这一现象。在多系统萎缩症患者的细胞中,翻译没有变化,这表明翻译的抑制是帕金森病特有的。这些发现表明,翻译的抑制是 LRRK2 在帕金森病病理中的一个近端功能。

相似文献

1
Protein synthesis is suppressed in sporadic and familial Parkinson's disease by LRRK2.LRRK2 抑制散发性和家族性帕金森病中的蛋白质合成。
FASEB J. 2020 Nov;34(11):14217-14233. doi: 10.1096/fj.202001046R. Epub 2020 Sep 14.
2
Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity.帕金森病相关的G2019S LRRK2诱导的多巴胺能神经变性依赖于激酶和GTP酶活性。
Proc Natl Acad Sci U S A. 2020 Jul 21;117(29):17296-17307. doi: 10.1073/pnas.1922184117. Epub 2020 Jul 6.
3
Phosphorylation of amyloid precursor protein by mutant LRRK2 promotes AICD activity and neurotoxicity in Parkinson's disease.突变型LRRK2对淀粉样前体蛋白的磷酸化作用促进帕金森病中的淀粉样前体蛋白胞内结构域(AICD)活性及神经毒性。
Sci Signal. 2017 Jul 18;10(488):eaam6790. doi: 10.1126/scisignal.aam6790.
4
Altered Development of Synapse Structure and Function in Striatum Caused by Parkinson's Disease-Linked LRRK2-G2019S Mutation.帕金森病相关的LRRK2-G2019S突变导致纹状体突触结构和功能的发育改变。
J Neurosci. 2016 Jul 6;36(27):7128-41. doi: 10.1523/JNEUROSCI.3314-15.2016.
5
Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson's disease.多巴胺 D2 受体介导的帕金森病 G2019S Lrrk2 基因突变模型中的神经保护作用。
Cell Death Dis. 2018 Feb 12;9(2):204. doi: 10.1038/s41419-017-0221-2.
6
LRRK2 kinase inhibitors reduce alpha-synuclein in human neuronal cell lines with the G2019S mutation.LRRK2 激酶抑制剂可降低携 G2019S 突变的人神经元细胞系中的α-突触核蛋白。
Neurobiol Dis. 2020 Oct;144:105049. doi: 10.1016/j.nbd.2020.105049. Epub 2020 Aug 13.
7
Development of a physiologically relevant and easily scalable LUHMES cell-based model of G2019S LRRK2-driven Parkinson's disease.开发一种基于 LUHMES 细胞的、具有生理相关性且易于扩展的 G2019S LRRK2 驱动的帕金森病模型。
Dis Model Mech. 2021 Jun 1;14(6). doi: 10.1242/dmm.048017. Epub 2021 Jun 11.
8
Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson's disease.核糖体蛋白 s15 磷酸化介导帕金森病中 LRRK2 的神经退行性变。
Cell. 2014 Apr 10;157(2):472-485. doi: 10.1016/j.cell.2014.01.064.
9
Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease.腺病毒介导的 G2019S LRRK2 的表达以激酶依赖的方式在帕金森病大鼠模型中诱导纹状体病理学。
Neurobiol Dis. 2015 May;77:49-61. doi: 10.1016/j.nbd.2015.02.019. Epub 2015 Feb 28.
10
LRRK2 activity does not dramatically alter α-synuclein pathology in primary neurons.LRRK2 活性不会显著改变原代神经元中的 α-突触核蛋白病理。
Acta Neuropathol Commun. 2018 May 31;6(1):45. doi: 10.1186/s40478-018-0550-0.

引用本文的文献

1
Unique nigral and cortical pathways implicated by epigenomic and transcriptional analyses in rotenone Parkinson's model.在鱼藤酮帕金森病模型中,表观基因组学和转录组学分析揭示的独特黑质和皮质通路。
NPJ Parkinsons Dis. 2025 Jul 24;11(1):217. doi: 10.1038/s41531-025-01049-1.
2
The modifying effect of mutant LRRK2 on mutant GBA1-associated Parkinson disease.突变型LRRK2对突变型GBA1相关帕金森病的修饰作用。
Hum Mol Genet. 2025 May 2. doi: 10.1093/hmg/ddaf062.
3
Chondroitin Sulfate-Coated Heteroduplex-Molecular Spherical Nucleic Acids.硫酸软骨素包被的异源双链分子球形核酸
Chembiochem. 2025 Mar 15;26(6):e202400908. doi: 10.1002/cbic.202400908. Epub 2024 Nov 28.
4
Protein Translation in the Pathogenesis of Parkinson's Disease.帕金森病发病机制中的蛋白质翻译。
Int J Mol Sci. 2024 Feb 18;25(4):2393. doi: 10.3390/ijms25042393.
5
Network Analysis Performed on Transcriptomes of Parkinson's Disease Patients Reveals Dysfunction in Protein Translation.对帕金森病患者转录组进行的网络分析揭示了蛋白质翻译功能障碍。
Int J Mol Sci. 2024 Jan 21;25(2):1299. doi: 10.3390/ijms25021299.
6
Early-stage idiopathic Parkinson's disease is associated with reduced circular RNA expression.早期特发性帕金森病与环状RNA表达降低有关。
NPJ Parkinsons Dis. 2024 Jan 20;10(1):25. doi: 10.1038/s41531-024-00636-y.
7
BEDwARS: a robust Bayesian approach to bulk gene expression deconvolution with noisy reference signatures.BEDwARS:一种具有稳健性的贝叶斯方法,可用于对具有噪声参考特征的批量基因表达解卷积。
Genome Biol. 2023 Aug 3;24(1):178. doi: 10.1186/s13059-023-03007-7.
8
LRRK2 Knockout Confers Resistance in HEK-293 Cells to Rotenone-Induced Oxidative Stress, Mitochondrial Damage, and Apoptosis.LRRK2 基因敲除可使 HEK-293 细胞抵抗鱼藤酮诱导的氧化应激、线粒体损伤和细胞凋亡。
Int J Mol Sci. 2023 Jun 22;24(13):10474. doi: 10.3390/ijms241310474.
9
Neuroprotective Effects of the Neural-Induced Adipose-Derived Stem Cell Secretome against Rotenone-Induced Mitochondrial and Endoplasmic Reticulum Dysfunction.神经营养性脂肪源干细胞分泌组对鱼藤酮诱导的线粒体和内质网功能障碍的神经保护作用。
Int J Mol Sci. 2023 Mar 15;24(6):5622. doi: 10.3390/ijms24065622.
10
Regulators of proteostasis are translationally repressed in fibroblasts from patients with sporadic and LRRK2-G2019S Parkinson's disease.蛋白质稳态调节因子在散发性和LRRK2 - G2019S帕金森病患者的成纤维细胞中受到翻译抑制。
NPJ Parkinsons Dis. 2023 Feb 6;9(1):20. doi: 10.1038/s41531-023-00460-w.